These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36028963)

  • 21. Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord.
    Zhao WC; Zhang B; Liao MJ; Zhang WX; He WY; Wang HB; Yang CX
    Neurosci Lett; 2014 Feb; 560():81-5. PubMed ID: 24370596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy.
    Bachewal P; Gundu C; Yerra VG; Kalvala AK; Areti A; Kumar A
    Biofactors; 2018 Mar; 44(2):109-122. PubMed ID: 29193444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle.
    Negi G; Kumar A; Joshi RP; Sharma SS
    Biochem Biophys Res Commun; 2011 Apr; 408(1):1-5. PubMed ID: 21439933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of antioxidants in redox regulation of diabetic cardiovascular complications.
    Turan B
    Curr Pharm Biotechnol; 2010 Dec; 11(8):819-36. PubMed ID: 20874678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Kaempferol isolated from seeds of Eruca sativa on changes of pain sensitivity in Streptozotocin-induced diabetic neuropathy.
    Kishore L; Kaur N; Singh R
    Inflammopharmacology; 2018 Aug; 26(4):993-1003. PubMed ID: 29159712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Diabetic Neuropathy: Focus on Oxidative Stress.
    Pang L; Lian X; Liu H; Zhang Y; Li Q; Cai Y; Ma H; Yu X
    Oxid Med Cell Longev; 2020; 2020():9524635. PubMed ID: 32832011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.
    Figueroa-Romero C; Sadidi M; Feldman EL
    Rev Endocr Metab Disord; 2008 Dec; 9(4):301-14. PubMed ID: 18709457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes, oxidative stress and therapeutic strategies.
    Rochette L; Zeller M; Cottin Y; Vergely C
    Biochim Biophys Acta; 2014 Sep; 1840(9):2709-29. PubMed ID: 24905298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of disorders of the prooxidant-antioxidant system in diabetes etiopathology].
    Mrowicka M
    Postepy Hig Med Dosw (Online); 2011 Aug; 65():534-41. PubMed ID: 21918256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy.
    Sood A; Kumar B; Singh SK; Prashar P; Gautam A; Gulati M; Pandey NK; Melkani I; Awasthi A; Saraf SA; Vidari G; Ozdemir M; Hussain FHS; Anwar ET; Ameen MSM; Gupta S; Porwal O
    Curr Pharm Des; 2020; 26(42):5468-5487. PubMed ID: 32851955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of diabetic complications: a chemical constituents based approach.
    Singh R; Kaur N; Kishore L; Gupta GK
    J Ethnopharmacol; 2013 Oct; 150(1):51-70. PubMed ID: 24041460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular death, reactive oxygen species (ROS) and diabetic complications.
    Volpe CMO; Villar-Delfino PH; Dos Anjos PMF; Nogueira-Machado JA
    Cell Death Dis; 2018 Jan; 9(2):119. PubMed ID: 29371661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease.
    Jakus V
    Bratisl Lek Listy; 2000; 101(10):541-51. PubMed ID: 11218944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of α-lipoic acid in diabetic neuropathy.
    Papanas N; Ziegler D
    Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEDICAL BASIS OF DIABETIC NEUROPATHY FORMATION (REVIEW).
    Archvadze A; Kistauri A; Gongadze N; Makharadze T; Chirakadze K
    Georgian Med News; 2018 Oct; (283):154-162. PubMed ID: 30516514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy.
    Kuhad A; Chopra K
    Neuropharmacology; 2009 Sep; 57(4):456-62. PubMed ID: 19555701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy.
    Low PA; Nickander KK; Tritschler HJ
    Diabetes; 1997 Sep; 46 Suppl 2():S38-42. PubMed ID: 9285497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic peripheral neuropathy: current perspective and future directions.
    Singh R; Kishore L; Kaur N
    Pharmacol Res; 2014 Feb; 80():21-35. PubMed ID: 24373831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.